Tanzeum - ) () ( .) GLP-1
The Promise of Repurposed Drugs However, the GLP-1 saga turns out, the fact that these drugs have popped up seemingly out of nowhere, and have generated such excitement, highlights the potential existing in the huge repurposed drug (drugs used in another condition than for which they are approved) market for these diseases
That depends.[Weight loss medication] should be very individualized based on your symptoms, medical conditions, eating habits, basal metabolic rate, and what [weight loss solutions] youve tried in the past, says Janese Laster, M.D., an obesity medicine specialist at Georgetown University Hospital
Exposure of the liver to xenobiotic substances means the body prepares itself by increasing detoxification enzymes, i.e., cytochrome P-450 mixed-function oxidase
Analysts forecast that the obesity drug market may be worth $105 billion in 2030 and could reach as high as $144 billion.